Skip to main content

Advertisement

Log in

Perioperative Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Recurrence of Cancer After Colorectal Resection: A Cohort Study Based on Prospective Data

  • Health Services Research and Global Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Perioperative use of nonsteroidal anti-inflammatory drugs (NSAIDs) is known to reduce inflammatory response in relation to surgery. Inflammation may promote recurrence of cancer, thus inhibition by use of NSAIDs could reduce recurrence after surgery.

Objective

The aim of this study was to examine the association between perioperative use of NSAIDs and cancer recurrence, as well as disease-free survival (DFS) and mortality after colorectal cancer surgery.

Methods

This was a cohort study based on data from a prospective clinical database, electronic medical records, and nationwide registers, and included patients from six major colorectal centers in Denmark. The primary outcome was cancer recurrence, while secondary outcomes included 5-year mortality and DFS.

Results

Overall, 2308 patients undergoing colorectal cancer surgery between 1 January 2006 and 31 December 2009 were included. A total of 909 patients received at least 2 days of treatment with NSAIDs, of whom 702 (77.2%) received ibuprofen and 204 (22.4%) received diclofenac. Cox regression analysis adjusting for NSAIDs resulted in decreased recurrence risk (adjusted hazard ratio [HRadjusted] 0.84, 95% confidence interval [CI] 0.72–0.99; p = 0.042). Competing risk analysis confirmed the finding, with an HRadjusted of 0.76 (95% CI 0.60–0.97; p = 0.026). There was no significant effect on mortality or DFS. Sensitivity analysis of the effect of ibuprofen reported an HRadjusted of 0.83 (95% CI 0.70–1.00; p = 0.047). In restricted analyses of localized disease only (Union for International Cancer Control [UICC] I–II) and elective surgery only, no effect was found (localized: HRadjusted 0.81, 95% CI 0.62–1.06, p = 0.12; elective: HRadjusted 0.85, 95% CI 0.72–1.01, p = 0.063).

Conclusions

Perioperative use of NSAIDs was associated with a reduced risk of cancer recurrence after resection for colorectal cancer. No effect on 5-year mortality or DFS was found.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Arias JI, Aller MA, Arias J. Surgical inflammation: a pathophysiological rainbow. J Transl Med. 2009;7:19.

    Article  Google Scholar 

  2. Weiss U. Inflammation. Nature. 2008;454(7203):427.

    CAS  PubMed  Google Scholar 

  3. Hiller JG, Perry NJ, Poulogiannis G, Riedel B, Sloan EK. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15(4):205–18.

    Article  Google Scholar 

  4. Oosterling SJ, van der Bij GJ, van Egmond M, van der Sijp JRM. Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur J Surg Oncol. 2005;31(1):29–37.

    Article  CAS  Google Scholar 

  5. Kelsey CR, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, et al. Metastasis dynamics for non-small-cell lung cancer: effect of patient and tumor-related factors. Clin Lung Cancer. 2013;14(4):425–32.

    Article  Google Scholar 

  6. Lee J-W, Shahzad MMK, Lin YG, Armaiz-Pena G, Mangala LS, Han H-D, et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res. 2009;15(8):2695–702.

    Article  Google Scholar 

  7. Dillekås H, Demicheli R, Ardoino I, Jensen SAH, Biganzoli E, Straume O. The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. Breast Cancer Res Treat. 2016;158(1):169–78.

    Article  Google Scholar 

  8. Isern AE, Manjer J, Malina J, Loman N, Martensson T, Bofin A, et al. Risk of recurrence following delayed large flap reconstruction after mastectomy for breast cancer. Br J Surg. 2011;98(5):659–66.

    Article  CAS  Google Scholar 

  9. Le CP, Nowell CJ, Kim-Fuchs C, Botteri E, Hiller JG, Ismail H, et al. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat Commun. 2016;7:10634.

    Article  CAS  Google Scholar 

  10. Glasner A, Avraham R, Rosenne E, Benish M, Zmora O, Shemer S, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a β-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol. 2010;184(5):2449–57.

    Article  CAS  Google Scholar 

  11. Yakar I, Melamed R, Shakhar G, Shakhar K, Rosenne E, Abudarham N, et al. Prostaglandin E 2 suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann Surg Oncol. 2003;10(4):469–79.

    Article  Google Scholar 

  12. Forget P, Vandenhende J, Berliere M, MacHiels JP, Nussbaum B, Legrand C, et al. Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg. 2010;110:1630–5.

    Article  CAS  Google Scholar 

  13. Desmedt C, Demicheli R, Fornili M, Bachir I, Duca M, Viglietti G, et al. Potential benefit of intra-operative administration of ketorolac on breast cancer recurrence according to the patient’s body mass index. J Natl Cancer Inst. 2018;110:1115–22.

    Article  Google Scholar 

  14. Yeh C-C, Lin J-T, Jeng L-B, Ho HJ, Yang H-R, Wu M-S, et al. Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: a nationwide cohort study. Ann Surg. 2015;261(3):521–6.

    Article  Google Scholar 

  15. Klein M, Andersen LPH, Harvald T, Rosenberg J, Gögenur I. Increased risk of anastomotic leakage with diclofenac treatment after laparoscopic colorectal surgery. Dig Surg. 2009;26(1):27–30.

    Article  CAS  Google Scholar 

  16. Lu ZR, Rajendran N, Lynch AC, Heriot AG, Warrier SK. Anastomotic leaks after restorative resections for rectal cancer compromise cancer outcomes and survival. Dis Colon Rectum. 2016;59(3):236–44.

    Article  Google Scholar 

  17. Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLoS Med. 2015;12(10):e1001885. https://doi.org/10.1371/journal.pmed.1001885.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kronborg O. Danish Colorectal Cancer Group (DCCG). Dan Med Bull. 2016;55(2):129.

    Google Scholar 

  19. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.

    Article  CAS  Google Scholar 

  20. Pedersen CB, Gøtzsche H, Møller JØ, Mortensen PB. The Danish civil registration system. A cohort of eight million persons. Dan Med Bull. 2006;53:441–9.

    PubMed  Google Scholar 

  21. Lynge E, Sandegaard J, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39:30–3.

    Article  Google Scholar 

  22. Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish national pathology registry and data bank. Clin Epidemiol. 2010;2(1):51–6.

    Article  Google Scholar 

  23. Klein M, Gogenur I, Rosenberg J. Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective data. BMJ. 2012;345:e6166.

    Article  Google Scholar 

  24. Lash TL, Riis AH, Ostenfeld EB, Erichsen R, Vyberg M, Thorlacius-Ussing O. A validated algorithm to ascertain colorectal cancer recurrence using registry resources in Denmark. Int J Cancer. 2015;136(9):2210–5.

    Article  CAS  Google Scholar 

  25. Fine JP, Gray RJ. A Proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–509

    Article  Google Scholar 

  26. Dannenberg AJ, Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell. 2003;4:431–6.

    Article  CAS  Google Scholar 

  27. Wang D, Dubois RN. Prostaglandins and cancer. Gut. 2006;55:115–22.

    CAS  PubMed  Google Scholar 

  28. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107(4):1183–8.

    Article  CAS  Google Scholar 

  29. Chan AT. Aspirin use and survival after diagnosis of colorectal cancer. JAMA. 2009;302(6):649–59.

    Article  CAS  Google Scholar 

  30. Fuchs C, Meyerhardt JA, Heseltine DL, Niedzwiecki D, Hollis D, Chan AT, et al. Influence of regular aspirin use on survival for patients with stage III colon cancer: findings from Intergroup trial CALGB 89803. J Clin Oncol. 2005;23(16 Suppl):3530.

    Article  Google Scholar 

  31. Morré DJ, Morre DM. tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal anti-inflammatory drugs (NSAIDS). Mol Cell Biochem. 2006;283(1–2):159–67.

    Article  Google Scholar 

  32. Reimers MS, Engels CC, Putter H, Morreau H, Liefers GJ, van de Velde CJH, et al. Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study. BMC Cancer. 2014;14(1):486.

    Article  Google Scholar 

  33. Arvind P, Papavassiliou ED, Tsioulias GJ, Qiao L, Lovelace CIP, Duceman B, et al. Prostaglandin E2Down-regulates the expression of HLA-DR antigen in human colon adenocarcinoma cell lines. Biochemistry. 1995;34(16):5604–9.

    Article  CAS  Google Scholar 

  34. Pichot Pla C, Ruiz López R. Diclofenac. DOLOR. 2004;19(4):227–36.

    Google Scholar 

  35. Orlando BJ, Lucido MJ, Malkowski MG. The structure of ibuprofen bound to cyclooxygenase-2. J Struct Biol. 2015;189(1):62–6.

    Article  CAS  Google Scholar 

  36. Matos P, Jordan P. Beyond COX-inhibition: “side-effects” of ibuprofen on neoplastic development and progression. Curr Pharm Des. 2015;21(21):2978–82.

    Article  CAS  Google Scholar 

  37. Modasi A, Pace D, Godwin M, Smith C, Curtis B. NSAID administration post colorectal surgery increases anastomotic leak rate: systematic review/meta-analysis. Surg Endosc. 2019;33(3):879–885.

    Article  Google Scholar 

  38. Branagan G, Finnis D. Prognosis after anastomotic leakage in colorectal surgery. Dis Colon Rectum. 2005;48(5):1021–6.

    Article  Google Scholar 

  39. Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, et al. Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer. Gut. 2011;60(4):491–8.

    Article  Google Scholar 

  40. Restivo A, Cocco IMF, Casula G, Scintu F, Cabras F, Scartozzi M, et al. Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer. Br J Cancer. 2015;113(8):1133–9.

    Article  CAS  Google Scholar 

  41. Nickelsen TN, Harling H, Kronborg O, Bulow S, Jorgensen T. The completeness and quality of the Danish Colorectal Cancer clinical database on colorectal cancer [in Danish]. Ugeskr Laeger. 2004;166(36):3092–5

    PubMed  Google Scholar 

  42. Colov EP, Fransgaard T, Klein M, Gögenur I. Validation of a register-based algorithm for recurrence in rectal cancer. Dan Med J. 2018;65(10):pii:5507.

    Google Scholar 

Download references

Funding

No sources of funding were used to assist in the preparation of this study.

Author information

Authors and Affiliations

Authors

Contributions

Anders Schack participated in study design, data collection, data analysis, data interpretation, and drafting and critical revision of the manuscript. Tina Fransgaard participated in study design, data collection, data analysis, data interpretation, and critical revision of the manuscript. Mads Klein participated in data collection, data interpretation, and critical revision of the manuscript. Ismail Gögenur participated in study design, data interpretation, and critical revision of the manuscript.

Corresponding author

Correspondence to Anders Schack MS.

Ethics declarations

Disclosure

Anders Schack, Tina Fransgaard, Mads Falk Klein, and Ismail Gögenur have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schack, A., Fransgaard, T., Klein, M.F. et al. Perioperative Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Recurrence of Cancer After Colorectal Resection: A Cohort Study Based on Prospective Data. Ann Surg Oncol 26, 3826–3837 (2019). https://doi.org/10.1245/s10434-019-07600-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-07600-8

Navigation